Evicenter
Datroway (datopotamab deruxtecan-dlnk) in HR-positive HER2-negative breast cancer
Manufacturer
Daiichi Sankyo, Inc.; AstraZeneca Pharmaceuticals LP
Prescribing information
Datroway (opens in a new tab)
Questions
42
Last updated

All questions

Dosing and administration: Datroway (datopotamab deruxtecan-dlnk) in HR-positive HER2-negative breast cancer

6 questions · 2 sources

Dosing

What is the maximum dose of DATROWAY?

What are the DATROWAY dose reduction levels?

What DATROWAY premedications and supportive medications (eye drops, mouthwash) are recommended?

What if a DATROWAY dose is missed or delayed?

Administration

How long does a DATROWAY infusion take?